Hacker News for Oct 23, 2025
Welcome to 'The Automated Daily', your ultimate source for a streamlined and insightful daily news experience. Please support this podcast by checking out our sponsors: -Get $10 off Perplexity.ai subscription - https://bit.ly/TheAutomatedDaily_Perplexity -Up to $1000 off the purchase of a Tesla Car - https://bit.ly/AutomatedDailyTesla Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily ETH: 0xAA874a9f4E8a163f84Dd321d0Ea669D7D11F43a6 BTC: bc1q3hrfjm2spc52rkem742c2nyg537t9dq6h50gvl DOGE: DRSJWXj1dy4Wtj1FMMgdcqJ1mEUpjZk3Ac SOL: 2GiJB87sSzt6kEhQ54L7NXQwAik5ACFTp3aRpqh76KBJ Today's topics: -Algorithms raise prices legally -US ends human-rights portal -PyTorch Monarch cluster control -VST 3 now MIT-licensed -Safe Browsing flags previews -ASN.1 compiler in D -FizzBuzz via combinators -C64 Blood Money retrospective -Hunt for missing PC Plus - https://www.bbc.com/news/articles/cqx30vnwd4do - https://bradley.chatha.dev/blog/dlang-propaganda/asn1-comp
Today's Hacker News Topics
- 01
Algorithms raise prices legally
— Algorithms raise prices legally - 02
US ends human-rights portal
— US ends human-rights portal - 03
PyTorch Monarch cluster control
— PyTorch Monarch cluster control - 04
VST 3 now MIT-licensed
— VST 3 now MIT-licensed - 05
Safe Browsing flags previews
— Safe Browsing flags previews - 06
ASN.1 compiler in D
— ASN.1 compiler in D - 07
FizzBuzz via combinators
— FizzBuzz via combinators - 08
C64 Blood Money retrospective
— C64 Blood Money retrospective - 09
Hunt for missing PC Plus
— Hunt for missing PC Plus
Sources & Hacker News References
More from Hacker News
- June 22, 2026 Codex logging bug and SSD wear & Deno Desktop packaging for apps
- June 21, 2026 iOS fingerprinting with public APIs & IPv6 crosses the 50% line
- June 20, 2026 Web experiments beyond WebGL & Favicon as micro data store
- June 19, 2026 GitHub clones spreading ZIP trojans & Fractal kernel reveals Apple speculation
- June 18, 2026 AI spa-style body imaging & Cheap academic drug repurposing trials